The second session of the WIPO Conversation on IP and AI is being held over three days from July 7 to 9, 2020. WIPO’s web page on the event is here. I had submitted comments earlier to both WIPO and… Continue Reading
KEI has a number of outstanding requests under the United States Freedom of Information Act (FOIA) for contracts related to biomedical innovations to control or treat the COVID-19 pandemic. On Thursday, June 25, and Friday, June 26, we received a… Continue Reading
On 14 May 2020, Bernd Lange, Chair of the European Parliament’s Committee on International Trade (INTA) wrote a letter to Phil Hogan (Commissioner for Trade, European Commission) on the “commercial aspects of intellectual property rights for medical products in the… Continue Reading
Statement of Knowledge Ecology International (KEI) on WHO Launch of the COVID-19 Technology Pool May 29, 2020. KEI supports the “WHO Solidarity Call to Action: To realize equitable global access to COVID-19 health technologies through pooling of knowledge, intellectual property… Continue Reading
(More on Moderna here: https://www.keionline.org/moderna) (Updated to include modernatx patents) The biotech company Moderna is in the news this week, after making an announcement of early clinical results for mRNA-1273, a vaccine candidate against novel coronavirus (SARS-CoV-2). The early and… Continue Reading
KEI is an accredited non-state actor at the World Health Organization (WHO). This is our statement at the 73rd World Health Assembly. https://extranet.who.int/nonstateactorsstatements/meetingoutline/6 Knowledge Ecology International Meeting: Seventy-third World Health Assembly Written statements on COVID-19 pandemic The biggest question today… Continue Reading
UPDATE: The World Health Organization has published the COVID-19 response resolution as a conference paper (A73/CONF./1) marked with the date of 18 May 2020. The sponsors of the draft resolution included: Albania, Australia, Bahrain, Bangladesh, Belarus, Bhutan, Bolivia (Plurinational State… Continue Reading
May 4, 2020 Comments of Knowledge Ecology International Regarding “Purple Book Enhancement; Establishment of a Public Docket; Request for Comments” (FDA-2020-N-0437) Knowledge Ecology International (KEI) provides the following comments regarding the Food and Drug Administration [FDA]’s Purple Book Enhancement. Our… Continue Reading
This annotated bibliography of (mostly scholarly and technical) articles and books on innovation prizes is a work on progress. In the past few years, there has been an explosion of research on innovation inducement prizes, much of which has yet… Continue Reading
On April 29, 2020, the United States Trade Representative (USTR) published its annual Special 301 Report. A PDF copy of the report is available here. KEI has compiled copies of the Special 301 Report for every year since its inception… Continue Reading